Cardinal Health, Inc. (NYSE:CAH) Receives $157.43 Average Price Target from Analysts

Shares of Cardinal Health, Inc. (NYSE:CAH - Get Free Report) have been assigned an average rating of "Moderate Buy" from the fourteen analysts that are presently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $158.07.

Several equities analysts have weighed in on CAH shares. UBS Group lifted their price objective on Cardinal Health from $150.00 to $160.00 and gave the company a "buy" rating in a report on Tuesday, April 29th. Robert W. Baird lifted their price objective on Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a report on Friday, May 2nd. Mizuho lifted their price objective on Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a report on Monday, March 31st. Morgan Stanley lifted their price objective on Cardinal Health from $181.00 to $190.00 and gave the company an "overweight" rating in a report on Wednesday. Finally, Citigroup reaffirmed a "neutral" rating and issued a $170.00 price objective (up from $157.00) on shares of Cardinal Health in a report on Friday, June 13th.

Cardinal Health Price Performance

CAH traded down $0.89 during trading on Wednesday, hitting $158.57. The stock had a trading volume of 105,108 shares, compared to its average volume of 2,225,267. The company has a 50 day moving average price of $158.45 and a 200-day moving average price of $139.91. The firm has a market cap of $37.85 billion, a price-to-earnings ratio of 24.74, a P/E/G ratio of 1.60 and a beta of 0.68. Cardinal Health has a one year low of $94.29 and a one year high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.15 by $0.20. The business had revenue of $54.88 billion during the quarter, compared to the consensus estimate of $55.33 billion. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The firm's quarterly revenue was up .0% on a year-over-year basis. During the same period in the previous year, the company posted $2.08 EPS. As a group, sell-side analysts predict that Cardinal Health will post 7.95 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st were issued a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 1.29%. The ex-dividend date of this dividend was Tuesday, July 1st. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's dividend payout ratio is presently 31.83%.

Hedge Funds Weigh In On Cardinal Health

Institutional investors and hedge funds have recently bought and sold shares of the company. Cyrus J. Lawrence LLC acquired a new position in Cardinal Health in the 4th quarter worth about $26,000. Greykasell Wealth Strategies Inc. acquired a new position in Cardinal Health in the 1st quarter worth about $26,000. Jones Financial Companies Lllp increased its stake in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock valued at $27,000 after buying an additional 14,034 shares during the period. Bellwether Advisors LLC acquired a new stake in shares of Cardinal Health in the fourth quarter valued at about $32,000. Finally, Tompkins Financial Corp increased its stake in shares of Cardinal Health by 106.7% in the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock valued at $34,000 after buying an additional 128 shares during the period. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.